Jill DeSimone, Director at Praxis Precision Medicines, sold PRAX on Jun 24, 2026
Data as of Oct 16
- Traded
- Jun 24, 2026
- Disclosed
- Jun 26, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
PRAX since disclosure
−26.2%
after the sale
Similar stocks (XLV) since disclosure
+10.2%
XLV — its sector index fund
Change in closing price from Jun 26, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLJill DeSimone DirectorPRAX Praxis Precision Medicines, Inc.$210Kdisclosed Jun 26 · filed 2 days after the trade
- ▼ SELLJill DeSimone DirectorPRAX Praxis Precision Medicines, Inc.$403Kdisclosed Jun 26 · filed 2 days after the trade
- ▼ SELLJill DeSimone DirectorPRAX Praxis Precision Medicines, Inc.$544Kdisclosed Jun 26 · filed 2 days after the trade
- ▼ SELLJill DeSimone DirectorPRAX Praxis Precision Medicines, Inc.$264Kdisclosed Jun 26 · filed 2 days after the trade
- ▼ SELLJill DeSimone DirectorPRAX Praxis Precision Medicines, Inc.$309Kdisclosed Jun 26 · filed 2 days after the trade
- ▼ SELLJill DeSimone DirectorPRAX Praxis Precision Medicines, Inc.$36.4Kdisclosed Jun 26 · filed 2 days after the trade
- ▼ SELLJill DeSimone DirectorPRAX Praxis Precision Medicines, Inc.$158Kdisclosed Jun 26 · filed 2 days after the trade
- ▼ SELLJill DeSimone DirectorPRAX Praxis Precision Medicines, Inc.$314Kdisclosed Jun 26 · filed 2 days after the trade
- ▼ SELLJill DeSimone DirectorPRAX Praxis Precision Medicines, Inc.$382Kdisclosed Jun 26 · filed 2 days after the trade
- ▼ SELLJill DeSimone DirectorPRAX Praxis Precision Medicines, Inc.$97.7Kdisclosed Jun 26 · filed 2 days after the trade
- ▼ SELLJill DeSimone DirectorPRAX Praxis Precision Medicines, Inc.$890Kdisclosed Jun 26 · filed 2 days after the trade